Found 1721 matching trials
Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 Expression PHASE2 The purpose of this study is to find out if there is a benefit of adding He...
Show More Location
Hays Medical Center
Learn More & Join Trial
An Observational Study of Current Practice Pattern on the Treatment of Women With Metastatic Breast Cancer Whose Tumors Overexpress Her2neu N/A The purpose of this study is to observe clinical outcomes of metastatic bre...
Show More Location
Cancer Research Network, Inc.
Learn More & Join Trial
This Study Aims to Optimize Neoadjuvant Therapy for HER2-positive Breast Cancer by Implementing a Dynamic Monitoring-guided Treatment Strategy. PHASE2 This study aims to optimize neoadjuvant therapy for HER2-positive breast ca...
Show More Location
Multiple Locations
Learn More & Join Trial
Assessment of Cardiotoxicity After Chemotherapy for Breast Cancer by Cardio-vascular Magnetic Resonance (MR) N/A Consecutive patients with a first diagnosis of breast cancer will be identi...
Show More Location
University of Calgary, Dept. of Cardiac Sciences and Tom Baker Cancer Centre
Learn More & Join Trial
Neoadjuvant Phase II Trial in Patients With T1c Operable, HER2-positive Breast Cancer According to TOP2A Status PHASE2 The main objective of this multicenter study will therefore be to evaluate ...
Show More Location
Institut de Cancerologie de L'Ouest - Site Paul Papin
Learn More & Join Trial
Safety Study of MGAH22 in HER2-positive Carcinomas PHASE1 The purpose of this study is to determine if MGAH22 is safe when given by i...
Show More Location
National Cancer Institute
Learn More & Join Trial
Brain Irradiation and Tremelimumab in Metastatic Breast Cancer NA The purpose of this study is to see if the combination of tremelimumab and ...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
Effects of Instrument-Assisted Constant-Speed Injection Versus Manual Injection on Pain From Large-Volume Subcutaneous Injection of Pertuzumab and Trastuzumab in Breast Cancer: A Randomized, Self-Controlled Study NA Research Background:Subcutaneous injection is an important route of adminis...
Show More Location
Medical Ethics Committee of Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Learn More & Join Trial
Analysis of Exploring Optimized Sequential Treatment Strategies of Antibody-Drug Conjugates (ADCs) in HER2-Low-Expressing Breast Cancer N/A This study retrospectively analyzes the clinical data of HER2-low breast ca...
Show More Location
Sun yat-sen University Cancer
Learn More & Join Trial
Decreasing Treatment for Metastatic HER2-Positive Breast Cancer With Undectable Cancer Levels in Blood Tests. PHASE2 Heroes is a multicentre, national, non-randomized, open-label, phase 2 stud...
Show More Location
Centre Eugène marquis
Learn More & Join Trial